NO822596L - Fremgangsmaate ved fremstilling av nye androstanderivater - Google Patents

Fremgangsmaate ved fremstilling av nye androstanderivater

Info

Publication number
NO822596L
NO822596L NO822596A NO822596A NO822596L NO 822596 L NO822596 L NO 822596L NO 822596 A NO822596 A NO 822596A NO 822596 A NO822596 A NO 822596A NO 822596 L NO822596 L NO 822596L
Authority
NO
Norway
Prior art keywords
procedure
preparation
new
image
derivatives
Prior art date
Application number
NO822596A
Other languages
English (en)
Other versions
NO159661C (no
NO159661B (no
Inventor
Dieter Bittler
Henry Laurent
Klaus Nickisch
Rudolf Wiechert
Manfred Albring
Annerose Schleusener
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO822596L publication Critical patent/NO822596L/no
Publication of NO159661B publication Critical patent/NO159661B/no
Publication of NO159661C publication Critical patent/NO159661C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0053 membered carbocyclic rings in position 12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO822596A 1981-07-29 1982-07-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive androstanderivater. NO159661C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten

Publications (3)

Publication Number Publication Date
NO822596L true NO822596L (no) 1983-01-31
NO159661B NO159661B (no) 1988-10-17
NO159661C NO159661C (no) 1989-01-25

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822596A NO159661C (no) 1981-07-29 1982-07-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive androstanderivater.

Country Status (17)

Country Link
US (2) US4457925A (no)
EP (1) EP0071153B1 (no)
JP (1) JPS5849400A (no)
AT (1) ATE22086T1 (no)
AU (1) AU558412B2 (no)
CA (1) CA1210754A (no)
DE (2) DE3130644A1 (no)
DK (1) DK164325B (no)
ES (1) ES514492A0 (no)
FI (1) FI78110C (no)
GB (1) GB2104899B (no)
GR (1) GR76872B (no)
IE (1) IE53711B1 (no)
IL (1) IL66311A (no)
NO (1) NO159661C (no)
PT (1) PT75334B (no)
ZA (1) ZA825480B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
CA2522784C (en) * 2003-04-01 2012-06-19 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use
US8084446B2 (en) 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (no) * 1968-11-13 1970-04-27
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
ES8305003A1 (es) 1983-04-16
US4457925A (en) 1984-07-03
NO159661C (no) 1989-01-25
DK164325B (da) 1992-06-09
EP0071153B1 (de) 1986-09-10
IL66311A (en) 1986-03-31
IE821824L (en) 1983-01-29
EP0071153A1 (de) 1983-02-09
GB2104899B (en) 1985-01-30
PT75334B (de) 1984-07-31
GR76872B (no) 1984-09-04
NO159661B (no) 1988-10-17
JPH033678B2 (no) 1991-01-21
ES514492A0 (es) 1983-04-16
IE53711B1 (en) 1989-01-18
DK327082A (da) 1983-01-30
AU558412B2 (en) 1987-01-29
US4587235A (en) 1986-05-06
AU8643982A (en) 1984-10-18
ATE22086T1 (de) 1986-09-15
CA1210754A (en) 1986-09-02
ZA825480B (en) 1983-11-30
FI78110B (fi) 1989-02-28
PT75334A (de) 1982-08-01
FI78110C (fi) 1989-06-12
DE3273186D1 (en) 1986-10-16
DE3130644A1 (de) 1983-02-17
GB2104899A (en) 1983-03-16
JPS5849400A (ja) 1983-03-23
FI822658A0 (fi) 1982-07-29
IL66311A0 (en) 1982-11-30
FI822658L (fi) 1983-01-30

Similar Documents

Publication Publication Date Title
NO822596L (no) Fremgangsmaate ved fremstilling av nye androstanderivater
SE7712891L (sv) Nya spirolaktoner och sett att framstella densammma
DK145627C (da) Analogifremgangsmaade til fremstilling af 9-substituerede hypoxanthinderivater
SE7711168L (sv) Nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner och forfarande for deras framstellning
ES526318A0 (es) Procedimiento para la obtencion de derivados de 1-hidroxietil-triazolilo sustituidos
FI880494A (fi) Nya 5-alkoxi-2,4-diaminoalkylbenzener samt dessa innehaollande haorfaergningsmedel.
SE8702361L (sv) Makrolidforeningar
ES401968A1 (es) Procedimiento para la preparacion de perhidrobenzindenos.
ATE16010T1 (de) Neue hydrocortison-derivate, ihre herstellung und verwendung.
ES529893A0 (es) Procedimiento para preparar derivados de tieno-tiazol
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
IE43248L (en) Araliphatic dihalogen compounds.
ES505328A0 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
ES519530A0 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
DK496283D0 (da) Fremgangsmade til fremstilling af 7alfa-acylthio-1alfa,2alfamethylen-3-oxo-17-alfa-pregn-4-en-21,17-carbolactoner
ES2037871T3 (es) Procedimiento para preparar 1-metil-androsta-1,4-dieno-3,17-diona y los nuevos productos intermedios para este procedimiento.
KR850000454A (ko) 세팔로스포린 유도체의 제조방법
ES550844A0 (es) Procedimiento para la obtencion de esteres del acido 4-hidroxilbenzoico con efecto supresor del sebo.
JPS552630A (en) 3,4-dihydrocarbostyril derivative